4 takeaways from 23&Me’s planned SPAC deal

4 takeaways from 23&Me’s planned SPAC deal

Source: 
MedCity News
snippet: 

Consumer DNA testing company 23andMe plans to go public through a merger with a special-purpose acquisition company started by Virgin Group. As sales of DNA testing kits wane, how will 23andMe drum up new interest for its business?